Antimicrobial Susceptibility Testing Market Analysis | CMI

1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

2. ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET ANALYSIS • Antimicrobial Susceptibility Testing Market, By Product Type (Manual Antimicrobial Susceptibility Testing Products {Susceptibility Testing Disks, Mic Strips, and Susceptibility Plates}, Automated Laboratory Instruments, and Consumables), By Application (Antibacterial, Antifungal, Anti-parasitic and Antiviral), By Method (Disk Diffusion, Rapid Automated AST, Broth Dilution, Gradient Diffusion, and Genotypic Methods), By End User (Hospitals, Pathology/Diagnostic Laboratories, Research and Academic Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

3. The global Antimicrobial Susceptibility Testing Market size was valued at US$ 2.65 billion in 2017 and is expected to witness a CAGR of 6.2% over the forecast period (2018 – 2026).

4. Global Antimicrobial Susceptibility Testing Market Share (%) Analysis, By Product Type, 2017

5. Market Drivers • Emergence of Multidrug Resistance Worldwide Is Expected To Drive the Antimicrobial Susceptibility Testing Market Revenue • Resistance among various microbial species to different antimicrobial drugs have emerged as a major cause of public health threat. According to World Health Organization (WHO), these resistant microorganisms such as bacteria, fungi, viruses, and parasites are able to combat attack by antimicrobial drugs, which leads to ineffective treatment resulting in persistence and spreading of infections. • Increasing number of multidrug resistance cases in tuberculosis (TB), malaria, HIV, influenza, and others among the global population is expected to result in increasing adoption of antimicrobial susceptibility testing to reduce the resistance exposure during the forecast period. For instance, according to the WHO, in 2016, an estimated 490,000 people worldwide developed MDR-TB. The countries with the largest numbers of MDR/RR-TB cases were China, India and the Russian Federation. • Moreover, development of genotypic-based methods offering rapid and accurate detection or confirmation of antimicrobial resistance is expected to drive the market growth. For instance, the Accelerate ID/AST System or ID/AST System (Accelerate) aims to reduce the turnaround time by using genetic methods. The device can identify infectious pathogens in a matter of hours instead of days, reducing diagnostic time by 30 to 50 hours.

6. Antimicrobial Susceptibility Testing Market Restraints • Stringent government regulations is the major restraining factor for the antimicrobial susceptibility testing market growth. Regulatory procedures creates barrier to AST development, as clinical validation and trials are lengthy and often too costly for small-sized or medium-sized enterprises or organizations. • For instance, in the U.S., a manufacturer who intends to market a device of generic type must conform to the general controls of Section 513(a)(1)(B) of the Federal Food, Drug and Cosmetic Act, address the risks to health associated with the AST system, and obtain a substantial equivalence assessment from the FDA.

7. Antimicrobial Susceptibility Testing Market - Regional Insights • On the basis of region, the global antimicrobial susceptibility testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be the most lucrative region in the antimicrobial susceptibility testing market in 2017 due to the emergence of a multidrug resistant strain of Salmonella in the U.S. For instance, according to the Centers for Disease Control and Prevention (CDC), September 2018, around two million people are infected with antibiotic-resistant bacteria in the U.S. annually and around 23,000 people die as a result. Moreover, government agencies in the U.S. have taken steps to prevent and control antibiotic resistance, which is expected to increase the adoption of antimicrobial susceptibility testing in the country. • Asia Pacific antimicrobial susceptibility testing market revenue is expected to foresee significant growth over the forecast period due to high prevalence of microbial infections and increasing consumption of antibiotics, eventually developing resistance among the population. According to a WHO report, in 2014, multidrug-resistant tuberculosis rates were high in India and treatment for the disease is generally limited.

8. Global Antimicrobial Susceptibility Testing Market Value (US$ Mn) & Y-o-Y Growth (%)

9. Key Players • Key players operating in the global antimicrobial susceptibility testing market include bioMérieux S.A., HiMedia Laboratories, Alifax Holding S.p.A., Creative Diagnostics, Resistell AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, and Bio-Rad Laboratories, Inc.

10. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Reference : https://www.coherentmarketinsights.com/market-insight/antimicrobial-susceptibility-testing-market-2449

11. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

12. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

13. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/